EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

miR-204-5p Protects Nephrin from Enzymatic Degradation in Cultured Mouse Podocytes Treated with Nephrotoxic Serum

George Haddad, Judith Blaine iD

Cells · 2025

DOI: 10.3390/cells14050364 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2025. Verfasst von George Haddad und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Renal Disease and Hypertension, Department of Medicine, School of Medicine, University of Colorado, Aurora, CO 80045, USA. Hauptthemen laut MEDLINE: MicroRNAs, Podocytes, Membrane Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nephrin is an essential constituent of the slit diaphragm of the kidney filtering unit. Loss of nephrin expression leads to protein leakage into the urine, one of the hallmarks of kidney damage. Autoantibodies against nephrin have been reported in patients with minimal change disease and recurrent focal segmental glomerulosclerosis. Understanding the mechanism of nephrin loss may help improve or lead to the development of novel treatment strategies. In this study, we demonstrated the important function of miR-204-5p expression on the protection of nephrin from anti-nephrin antibodies present in nephrotoxic serum (NTS). In addition, we identified that aspartyl protease cathepsin D is one enzyme that may be involved in nephrin enzymatic degradation and that cathepsin D is a direct target of miR-204-5p gene regulation. The regulation of miR-204-5p expression was determined to be regulated by the long noncoding RNA Josd1-ps. In an NTS in vivo animal model, treatment with the pan aspartic protease inhibitor Pepstatin A ameliorated renal damage. Finally, we showed that the expression of miR-204-5p had a nephrin-protecting function in vitro. Developing a method of delivery of miR-204-5p specifically to podocytes in vivo may provide a novel method of nephroprotection against nephrin autoantibodies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsPodocytesMembrane ProteinsAnimalsMiceCathepsin DProteolysisHumansMice, Inbred C57BL

Stichwörter der Autor:innen

autoantibodieslncJosd1-psmiR-204-5pnephrinnephrotoxic serumpepstatin Apodocytes

Substanzen

MicroRNAsnephrinMembrane ProteinsCathepsin D

Autor:innen und Institutionen

  • Division of Renal Disease and Hypertension, Department of Medicine, School of Medicine, University of Colorado, Aurora, CO 80045, USA.
  • Division of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus, 12700 E 19th Ave, Aurora, CO 80045, USA.

ORCID-Profile: Judith Blaine

Förderung

  • NIDDK NIH HHS
  • National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Zitieren

APA

Haddad, G., & Blaine, J. (2025). miR-204-5p Protects Nephrin from Enzymatic Degradation in Cultured Mouse Podocytes Treated with Nephrotoxic Serum. Cells. https://doi.org/10.3390/cells14050364

Vancouver

Haddad G, Blaine J. miR-204-5p Protects Nephrin from Enzymatic Degradation in Cultured Mouse Podocytes Treated with Nephrotoxic Serum. Cells. 2025. doi:10.3390/cells14050364

BibTeX
@article{Haddad2025,
  author = {Haddad, George and Blaine, Judith},
  title = {miR-204-5p Protects Nephrin from Enzymatic Degradation in Cultured Mouse Podocytes Treated with Nephrotoxic Serum},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14050364}
}
Kostenlos starten →